Skip to main content
2025 ACVIM Forum Main banner
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
Poster
Poster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
ACVIM Resident Research Award Winner
ACVIM Resident Research Award Winner
Cardiology Research Abstract Award Winner
Cardiology Research Abstract Award Winner
Back

Philip J. Bergman, DVM, PhD, DACVIM-Oncology

NA
NA
Stamford, Connecticut, United States

Dr. Bergman is the is the principal veterinary investigator for the fully licensed canine melanoma vaccine (Oncept). Dr. Bergman is also an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center. Dr. Bergman was the Global Director of Clinical Studies for MVH in 2024 and VCA from 2013 to 2023. He served as the CMO for BrightHeart Veterinary Centers and was the head of the DACC at AMC. CSU DVM then intern at KSU and returned to CSU for his medical oncology residency and then completed a PhD Fellowship from the M.D. Anderson Cancer Center in Houston (94-99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.

Disclosure information not submitted.

Presentation(s):